Company THC Farmaceuticals, Inc. Other OTC
Equities
CBDG
US87243T1007
Drug Retailers
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Novel Cannabinoid-based Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -70.51% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -70.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Grossman
CEO | Chief Executive Officer | - | - |
Gary Henrie
LAW | General Counsel | 70 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Tobias
BRD | Director/Board Member | 73 | - |
Mark Grossman
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,131,600 | 3,738,000 ( 20.62 %) | 1,500,000 ( 8.273 %) | 20.62 % |
Company contact information
THC Farmaceuticals, Inc.
1000 Newbury Road Suite 138-B
91320, Thousand Oaks
+480-725-9060
http://www.cbdg.comSector
1st Jan change | Capi. | |
---|---|---|
+4.24% | 2.69B | |
-4.59% | 1.42B | |
+64.90% | 558M | |
+60.09% | 198M | |
-2.51% | 94.66M | |
-21.80% | 81.6M | |
+31.25% | 60.4M | |
+35.96% | 55.06M |